Report title: Celgene Corp. at Oppenheimer & Co. Healthcare Conference Transcript
from Thomson StreetEvents
10 page (5596 word) report published Nov 04, 2009

Price $54.00 available for immediate download
Report Overview
 
Search Inside
 
About Thomson StreetEvents

Abstract: Final Transcript of CELG presentation, 4-Nov-09 10:15am ET

Brief Excerpt: ...Brian Aberman - Oppenheimer - Analyst Our next presenting company really needs no introduction. It's one of the largest biotech companies, and as you all probably well know, Celgene is a global leader in the treatment of hematologic malignancies, with a broad platform of oncology and inflammation candidates. It's my great pleasure to introduce Celgene's Chairman and CEO, Dr. Sol Barer. Dr. Sol Barer - Celgene Corp. - Chairman & CEO Thank you, Brian. It's a pleasure to be here and give you a short overview and perspective on the progress we've made at Celgene. Before I begin, I'm obligated to say that I'll be making certain forward-looking statements. Our vision and our objective at Celgene is to build a preeminent company in our area of focus, the discovery, the development, and the commercialization of products for the treatment of hematology, cancer, and serious immune-inflammatory diseases. We've made significant progress on this. We're in an excellent strategic position. We're expanding...

Report Type: Transcript
Source: Thomson StreetEvents
Company: Celgene Corp.
Ticker: CELG
Time: 10:15am ET
Free Sample: Click Here to Download
Format:
PDF Adobe Acrobat


Enter the keyword(s) which you would like to search for within this document and click "Search"  

Also from Thomson StreetEvents

Price: $54.00



  Can't Decide?

Purchasing premium research sight unseen can be intimidating. At Alacra we want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.